Blue Cross partners with Onduo to provide diabetes management wearable

Blue Cross and Blue Shield has announced a partnership with Onduo, an Alphabet-backed wearable device for the monitoring of glucose levels in diabetic patients.

A year after the launch of Onduo by Alphabet, with the aim to produce technologies for the improved self-management of diabetes, the partnership with Blue Cross will provide individuals the ability to improve health outcomes with the technology.

“We’re working on finding those innovations in the market that will move the needle and improve our (health plan) members' lives,” said Maureen Sullivan, Blue Cross and Blue Shield Association senior vice president and chief strategy officer.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”